View in EDS

PIK-75 overcomes venetoclax resistance via blocking PI3K-AKT signaling and MCL-1 expression in mantle cell lymphoma.

Saved in:
Bibliographic Details
Title: PIK-75 overcomes venetoclax resistance via blocking PI3K-AKT signaling and MCL-1 expression in mantle cell lymphoma.
Authors: Huang S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA., Liu Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA., Chen Z; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA., Wang M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA.; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA., Jiang VC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA.
Source: American journal of cancer research [Am J Cancer Res] 2022 Mar 15; Vol. 12 (3), pp. 1102-1115. Date of Electronic Publication: 2022 Mar 15 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: e-Century Pub. Corp Country of Publication: United States NLM ID: 101549944 Publication Model: eCollection Cited Medium: Print ISSN: 2156-6976 (Print) Linking ISSN: 21566976 NLM ISO Abbreviation: Am J Cancer Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35411248
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: PIK-75 overcomes venetoclax resistance via blocking PI3K-AKT signaling and MCL-1 expression in mantle cell lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Huang+S%22">Huang S</searchLink>; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Chen+Z%22">Chen Z</searchLink>; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Wang+M%22">Wang M</searchLink>; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA.; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Jiang+VC%22">Jiang VC</searchLink>; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101549944%22">American journal of cancer research</searchLink> [Am J Cancer Res] 2022 Mar 15; Vol. 12 (3), pp. 1102-1115. <i>Date of Electronic Publication: </i>2022 Mar 15 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22e-Century+Pub%2E+Corp%22">e-Century Pub. Corp </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101549944 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2156-6976 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221566976%22">21566976 </searchLink><i>NLM ISO Abbreviation: </i>Am J Cancer Res <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35411248
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1102
    Titles:
      – TitleFull: PIK-75 overcomes venetoclax resistance via blocking PI3K-AKT signaling and MCL-1 expression in mantle cell lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Huang S
      – PersonEntity:
          Name:
            NameFull: Liu Y
      – PersonEntity:
          Name:
            NameFull: Chen Z
      – PersonEntity:
          Name:
            NameFull: Wang M
      – PersonEntity:
          Name:
            NameFull: Jiang VC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 03
              Text: 2022 Mar 15
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2156-6976
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: American journal of cancer research
              Type: main
ResultId 1